Published in AIDS Vaccine Week, October 31st, 2005
Study 1: Vascular changes are greater in HIV-infected children exposed to protease inhibitors.
According to recent research from England, "Premature cardiovascular disease is increasingly recognized in HIV-infected patients, but the mechanisms involved are unclear. The purpose of this study was to determine the impact of HIV infection and antiretroviral therapy (ART) on markers of early vascular disease in children.
"We studied 83 HIV-infected children (56 had taken ART, of whom 31 received a regimen containing protease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Vaccine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.